triiodothyronine has been researched along with cilazapril, anhydrous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asahi, T; Oshiro, Y; Shimabukuro, M; Takasu, N; Yoshida, H | 1 |
1 other study(ies) available for triiodothyronine and cilazapril, anhydrous
Article | Year |
---|---|
Cilazapril prevents cardiac hypertrophy and postischemic myocardial dysfunction in hyperthyroid rats.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Cell Size; Cilazapril; Coronary Circulation; Hemodynamics; Hyperthyroidism; Hypertrophy, Left Ventricular; Male; Myocardial Ischemia; Myocardium; Organ Size; Oxygen Consumption; Propranolol; Rats; Rats, Sprague-Dawley; Triiodothyronine | 2001 |